Summit Therapeutics Inc. Annual Earnings Per Share, Basic in USD/shares from 2017 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Summit Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2017 to 2023.
  • Summit Therapeutics Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.08 USD/shares, a 167% decline year-over-year.
  • Summit Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was 0.26 USD/shares.
  • Summit Therapeutics Inc. annual Earnings Per Share, Basic for 2023 was -0.99 USD/shares, a 141% decline from 2022.
  • Summit Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -0.41 USD/shares, a 38.8% increase from 2021.
  • Summit Therapeutics Inc. annual Earnings Per Share, Basic for 2021 was -0.67 USD/shares, a 11.8% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 -$1 -141% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $0 +$0.26 +38.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$1 +$0.09 +11.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$1 +$0.13 +14.6% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-12-21
2019 -$1 -$2 -241% Feb 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $0.63 +$2.64 Feb 1, 2018 Jan 31, 2019 10-K 2021-03-31
2017 -$2 Feb 1, 2017 Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.